@article{ref1,
title="Screening for intimate partner violence during pregnancy: a test accuracy study",
journal="European journal of public health",
year="2022",
author="Zapata-Calvente, Antonella Ludmila and Megías, Jesús L. and Velasco, Casilda and Caño, Africa and Khan, Khalid S. and Rubio, Leticia and Martin-de-Las-Heras, Stella",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="BACKGROUND: Intimate partner violence (IPV) against women is a serious health problem that affects pregnancy more frequently than other obstetric complications usually evaluated in antenatal visits. We aimed to estimate the accuracy of the Women Abuse Screening Tool-Short (WAST-Short) and the Abuse Assessment Screen (AAS) for the detection of IPV during and before pregnancy. <br><br>METHODS: Consecutive eligible mothers in 21 public primary health antenatal care centres in Andalusia (Spain) who received antenatal care and gave birth during January 2017-March 2019, had IPV data gathered by trained midwives in the first and third pregnancy trimesters. The index tests were WAST-Short (score range 0-2; cut-off 2) and AAS (score range 0-1; cut-off 1). The reference standard was World Health Organization (WHO) IPV questionnaire. Area under receiver operating characteristics curve (AUC), sensitivity and specificity with 95% confidence intervals (CI) were estimated for test performance to capture IPV during and before pregnancy, and compared using paired samples analysis. <br><br>RESULTS: According to the reference standard, 9.5% (47/495) and 19.4% (111/571) women suffered IPV during and before pregnancy, respectively. For capturing IPV during pregnancy in the third trimester, the WAST-Short (AUC 0.73, 95% CI 0.63, 0.81), performed better than AAS (AUC 0.57, 95% CI 0.47, 0.66, P = 0.0001). For capturing IPV before pregnancy in the first trimester, there was no significant difference between the WAST-Short (AUC 0.69, 95% CI 0.62, 0.74) and the AAS (AUC 0.69, 95% CI 0.62, 0.74, P = 0.99). <br><br>CONCLUSIONS: The WAST-Short could be useful to screen IPV during pregnancy in antenatal visits.<p /> <p>Language: en</p>",
language="en",
issn="1101-1262",
doi="10.1093/eurpub/ckac009",
url="http://dx.doi.org/10.1093/eurpub/ckac009"
}